GlassScriptPhysician profile
Eve M Katzen
NPI 1053439562
$6,641.81
in general payments reported to CMS, 2019-2025
23 companies · $23.32 in 2025
The $23.32 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $955 · 2022: $1,244 · 2023: $1,970 · 2024: $2,450 · 2025: $23.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,443.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,669.80 | 2021-2025 | |
| Genzyme Corporation | $714.50 | 2021-2024 | |
| Janssen Biotech, INC. | $497.21 | 2021-2024 | Tremfya |
| Incyte Corporation | $444.53 | 2021-2024 | Opzelura |
| Pfizer INC. | $419.34 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $382.16 | 2021-2024 | |
| Lilly USA, LLC | $361.39 | 2021-2024 | Taltz, Olumiant, Ebglyss |
| Sun Pharmaceutical Industries INC. | $354.19 | 2021-2024 | Winlevi |
| Galderma Laboratories, L.P. | $324.16 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $264.38 | 2022-2024 | Dupixent |
| Leo Pharma INC. | $206.91 | 2022-2024 | Adbry |
| Arcutis Biotherapeutics, INC. | $203.13 | 2023-2024 | Zoryve |
| Mayne Pharma Commercial LLC | $189.12 | 2021-2024 | |
| Ucb, INC. | $122.36 | 2022-2024 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $110.80 | 2022-2024 | Sotyktu |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $92.69 | 2021-2022 | |
| Almirall LLC | $82.00 | 2021-2024 | Seysara |
| Biofrontera INC. | $65.71 | 2021 | |
| Amgen INC. | $49.20 | 2023 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.64 | 2021 | |
| Dermavant Sciences, INC. | $24.13 | 2024 | Vtama |
| Blueprint Medicines Corporation | $21.36 | 2023 | Ayvakit |
| Medimetriks Pharmaceuticals, INC. | $18.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eve Katzen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.